CCI Clears Synthimed Labs Acquisition of Ind Swift, Essix Units
The Competition Commission of India (CCI) has approved the proposed acquisition of certain business undertakings of Ind Swift Laboratories Ltd and Essix Biosciences Ltd by Synthimed Labs Private Ltd. The transaction involves the proposed slump sale of certain business undertakings of Ind Swift Laboratories Ltd (ISLL) and Essix Biosciences Ltd to Synthimed Labs Pvt Ltd.
Click it and Unblock the Notifications
Sign in with Google